Press Release: FDA Advisory Committee unanimously recommends nirsevimab as first immunization against RSV disease for all infants

https://ift.tt/O5yCvfT

FDA Advisory Committee unanimously recommends nirsevimab as first immunization against RSV disease for all infants



from Sanofi - Aventis Groupe https://ift.tt/S2KU4et
via IFTTT

Post a Comment

0 Comments